Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome

BACKGROUND: Abciximab reduces major adverse cardiac events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention (pPCI). Standard protocol is intravenous abciximab bolus during PCI plus abciximab infusion for 12–18 h post pPCI. Intracoronary (IC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakoor, Muhammad Tariq, Ayub, Samia, Dhakam, Sajid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801446/
https://www.ncbi.nlm.nih.gov/pubmed/29450173
http://dx.doi.org/10.1016/j.ijchv.2014.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801446/
https://www.ncbi.nlm.nih.gov/pubmed/29450173
http://dx.doi.org/10.1016/j.ijchv.2014.03.007

Ejemplares similares